pipette
ESEspañol

A smart photothermal microneedle system for dual-targeted therapy of osteoarthritis via MMPs inhibition

Yuxuan Hou, Wen Niu, Wenpin Qin, Weixiao Wang, Jialu Gao, Haoyan Zhao, 苟胜文, Xiaoxiao Han, Yubo Liu, Kairan Ban, Longying Sun, Xinzhao Chen, Guang Zeng, Dechun Liu, Kai Jiao

Peer-reviewed journalReal-world use

In the authors' words

Temporomandibular joint osteoarthritis (TMJ-OA) causes chronic pain, cartilage degeneration and pathological neurovascular remodeling, yet effective local therapies remain limited. Here we develop a minimally invasive near-infrared (NIR)-responsive microneedle system (SFZICC MNs) that integrates cryptochlorogenic acid (CCA)- and carbon quantum dot-loaded ZIF-8 nanoparticles within a methacrylated silk fibroin hydrogel. The system provides mechanical integrity, photothermal responsiveness and NIR-assisted local drug release. In a mouse TMJ-OA model, SFZICC MNs combined with NIR irradiation reduce mechanical hypersensitivity, anxiety-like behaviors, cartilage degeneration and pathological neurovascularization, and outperform free CCA, blank microneedles and drug-loaded microneedles without NIR. Mechanistically, CCA directly interacts with MMP3, MMP9 and MMP13 and moderately inhibits their catalytic activities in vitro, while reducing intracellular superoxide accumulation, NF-κB p65 phosphorylation and MMP protein abundance. In vivo imaging further supports reduced overall MMP-associated proteolytic activity. These findings support SFZICC MNs as a locally responsive therapeutic platform for TMJ-OA. Temporomandibular joint osteoarthritis (TMJ-OA) lacks effective local therapies. Here, the authors develop an NIR-responsive microneedle patch that locally delivers cryptochlorogenic acid (CCA), reduces pain and cartilage degeneration, and suppresses MMP-associated pathological remodeling.

Main resultThe abstract does not state a limitation.

Appeared: Sunday, October 18. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-78588-5